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1.1   WHAT IS BIS(2-CHLOROETHYL) ETHER? 
 
Bis(2-chloroethyl) ether (BCEE) is a colorless non-flammable liquid 
with a strong, unpleasant odor. It does not occur naturally, but is 
manufactured by humans for use in the production of pesticides and other 
chemicals. Limited amounts of BCEE will dissolve in water, and it also 
will slowly evaporate into air. In the environment, BCEE is broken down 
by bacteria in soil and water and by chemical reactions in the air, so 
it does not tend to persist for long periods. Further information on 
the properties and uses of BCEE, and how it behaves in the environment, 
is presented in Chapters 3, 4 and 5. 
 
1.2    HOW MIGHT I BE EXPOSED TO BCEE? 
 
Exposure to BCEE is most likely to occur in or near chemical plants 
where it is made or used, or near waste sites where it has been 
improperly disposed of. One way exposure might occur is through 
consumption of drinking water that contains BCEE. Low levels (0.01 to 
0.5 parts per billion (ppb)) of BCEE have been detected in the drinking 
water supplies of several cities, and higher levels (840 ppb) have been 
detected in underground water near some chemical waste sites. Although 
BCEE evaporates relatively slowly, exposure might also occur through 
breathing BCEE vapors near areas where it is used or stored. However, 
no information exists on the levels of BCEE in outdoor air. Further 
discussion of how people may be exposed to BCEE is presented in 
Chapter 5. 
 
1.3   HOW CAN  BCEE ENTER AND LEAVE MY BODY? 
 
BCEE enters the body easily after being swallowed in food or water, 
or after being inhaled in air. It may also enter by crossing the skin 
when dermal contact occurs. Once inside the body, BCEE is broken down 
to a number of different chemicals, and these are eliminated in the 
urine or the breath. Most BCEE which enters the body is removed in this 
way within two to three days, so BCEE does not tend to accumulate in the 
body. Further information on how BCEE enters and leaves the body is 
presented in Chapter 2. 
 
1.4    HOW CAN BCEE AFFECT MY HEALTH? 
 
People exposed to BCEE vapors report that it is highly irritating 
to the eyes and the nose. Animal studies show that BCEE vapors can 
cause severe injury to the lungs, and may lead to death. Mice given 













suggests that BCEE might cause cancer in humans, although no cases of 
cancer due to BCEE have been reported in people and BCEE was also not 
found to induce excess cancer after feeding to rats. Effects of BCEE on 
other organs and body functions have not been well studied, and it is 
not known if BCEE impairs reproduction or the development of fetuses. 
Further information on the possible health effects of BCEE is presented 
in Chapter 2. 
 
1.5   IS THERE A MEDICAL TEST TO DETERMINE IF I HAVE BEEN EXPOSED TO 
BCEE? 
 
Although there are chemical tests that can identify and measure 
BCEE, these have not been developed for measuring BCEE in humans. 
Further information on the methods used to measure BCEE is presented in 
Chapter 6. 
 
1.6   WHAT LEVELS OF EXPOSURE HAVE RESULTED IN HARMFUL HEALTH EFFECTS? 
 
Tables 1-l through l-4 show the relationship between exposure to 
BCEE and known health effects. A Minimal Risk Level (MRL) is also 
included in Table l-l. This MRL was derived from animal data for longterm 
exposure, as described in Chapter 2 and in Table 2-1. This MRL 
provides a basis for comparison with levels that people might encounter 
in air. If a person is exposed to BCEE at an amount below the long-term 
MRL, it is not expected that harmful noncancer health effects will 
occur. Because this level is based only on information currently 
available, some uncertainty is always associated with it. Also, because 
the method for deriving MRLs does not use any information about cancer, 
a MRL does not imply anything about the presence, absence, or level of 
risk of cancer. 
 
Based on studies in animals, if an amount of BCEE equal to 1 to 
2 fluid ounces entered the body across the skin, death could result. 
Skin contact with even small amounts (less than a drop) of liquid BCEE 
will cause irritation to the skin. 
 
Further information on the amounts of BCEE that cause health 















1.7   WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT  HUMAN  
HEALTH ? 
 
The Federal government has taken a number of steps to reduce the 
possibility of human exposure to BCEE. The U.S. Environmental 
Protection Agency (EPA) has developed rules and regulations that limit 
the amount of BCEE that can be discharged into water or air from 
industrial sources as well as how it is to be disposed of at waste 
sites. Levels of BCEE exposure in the workplace are strictly regulated 
by the Occupational Safety and Health Administration (OSHA), since BCEE 
is considered a probable human carcinogen. Further information on 
regulations which apply to BCEE is presented in Chapter 7. 
 
1.8   WHERE CAN I GET MORE INFORMATION? 
 
If you have further questions or concerns, please contact your 
State Health or Environmental Department or: 
 
Agency for Toxic Substances and Disease Registry 
Division of Toxicology 
1600 Clifton Road, E-29 








2.    HEALTH  EFFECTS 
 
2.1    INTRODUCTION 
 
This chapter contains descriptions and evaluations of studies and 
interpretation of data on the health effects associated with exposure to 
BCEE. Its purpose is to present levels of significant exposure for BCEE 
based on toxicological studies, epidemiological investigations, and 
environmental exposure data. This information is presented to provide 
public health officials, physicians, toxicologists, and other interested 
individuals and groups with .(l) an overall perspective of the toxicology 
of BCEE and (2) a depiction of significant exposure levels associated 
with various adverse health effects. 
 
Bis(chloroethy1) ether (BCEE) occurs in two isomeric forms: 
bis(l-chloroethyl) ether, or alpha BCEE, and bis(2-chloroethyl) ether, 
or beta BCEE. The alpha isomer is chemically more reactive than the 
beta isomer, but it has had little industrial use and there are very few 
data on the toxicological effects of this isomer. The beta form is more 
stable and has been widely produced and used by industry. It is the 
beta isomer (bis(2-chloroethyl) ether) that is referred to as BCEE in 
the remainder of this document. 
 
2.2   DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE 
 
To help public health professionals address the needs of persons 
living or working near hazardous waste sites, the data in this section 
are organized first by route of exposure--inhalation, oral, and dermal-- 
and then by health effect--death, systemic, immunological, neurological, 
developmental, reproductive, genotoxic, and carcinogenic effects. These 
data are discussed in terms of three exposure periods--acute, 
intermediate, and chronic. 
 
Levels of significant exposure for each exposure route and duration 
(for which data exist) are presented in tables and illustrated in 
figures. The points in the figures showing no-observed-adverse-effect 
levels (NOAELs) or lowest-observed-adverse-effect levels (LOAELS) 
reflect the actual doses (levels of exposure) used in the studies. 
LOAELs have been classified into "less serious" or "serious" effects. 
These distinctions are intended to help the users of the document 
identify the levels of exposure at which adverse health effects start to 
appear, determine whether or not the intensity of the effects varies 
with dose and/or duration, and place into perspective the possible 












The significance of the exposure levels shown on the tables and 
graphs may differ depending on the user's perspective. For example, 
physicians concerned with the interpretation of clinical findings in 
exposed persons or with the identification of persons with the potential 
to develop such disease may be interested in levels of exposure 
associated with "serious" effects. Public health officials and project 
managers concerned with response actions at Superfund sites may want 
information on levels of exposure associated with more subtle effects in 
humans or animals (LOAEL) or exposure levels below which no adverse 
effects (NOAEL) have been observed. Estimates of levels posing minimal 
risk to humans (minimal risk levels, MRLs) are of interest to health 
professionals and citizens alike. 
 
For certain chemicals, levels of exposure associated with 
carcinogenic effects may be indicated in the figures. These levels 
reflect the actual doses associated with the tumor incidences reported 
in the studies cited. Because cancer effects could occur at lower 
exposure levels, the figures also show estimated excess risks, ranging 
from a risk of one in 10,000 to one in 10,000,000 (10-4 to 10-7), as 
developed by EPA. 
 
Estimates of exposure levels posing minimal risk to humans (MRLs) 
have been made, where data were believed reliable, for the most 
sensitive noncancer end point for each exposure duration. MRLs include 
adjustments to reflect human variability and, where appropriate, the 
uncertainty of extrapolating from laboratory animal data to humans. 
Although methods have been established to derive these levels (Barnes 
et al. 1987; EPA 1980c), uncertainties are associated with the 
techniques. 
 
2.2.1  Inhalation Exposure 
 
Table 2-l and Figure 2-1 summarize the available toxicity data for 
inhalation exposure to BCEE, and these data are discussed below. 
 
2.2.1.1  Death 
 
One case of a human fatality attributed to inhalation of BCEE 
vapors in a fulling mill was reported by Elkins (1959), but no details 
were provided. In animals, acute inhalation lethality depends on the 
level and duration of exposure to BCEE. Exposure of animals (rats, mice 
guinea pigs, rabbits) to concentrations of 500-1,000 ppm caused death 
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Union Carbide 1948). Exposure of rats to 250 ppm for 4 hours caused 
death in about half the animals (Carpenter et al. 1949), while exposure 
of mice, rats, and rabbits to 200 ppm for 1 hour did not cause any 
deaths (Union Carbide 1948). Four of six guinea pigs exposed to 105 ppm 
for 13 hours died within four hours after the exposure, while no deaths 
occurred in animals exposed to 35 ppm for 13.5 hours (Schrenk et al. 
1933). Animals exposed to BCEE vapors display marked signs of 
respiratory distress, and acute lung injury appears to be the principal 
cause of death (Carpenter et al. 1949). The highest NOAEL values and 
all reliable LOAEL values for death in each species and duration 
category are recorded in Table 2-l and plotted in Figure 2-l. The 
values of 105 ppm (Schrenk et al. 1933) and 250 ppm (Carpenter et al. 
1949) are presented in Table l-2. 
 
2.2.1.2   Systemic Effects 
 
Respiratory Effects. The principal acute effect of inhalation 
exposure to BCEE vapor is irritation and injury to the cells of the 
respiratory epithelium. In humans, exposure to concentrations of 
550 ppm or higher produces extreme irritation and cannot be tolerated 
for more than a few moments (Schrenk et al. 1933). Exposure to 260 ppm 
is highly irritating, but is tolerable for brief periods. Irritation is 
mild at 100 ppm, and minimal at 35 ppm (Schrenk et al. 1933). These 
values have been presented in Table l-l. 
 
Studies in guinea pigs provide similar findings, with 35 ppm 
producing mild nasal irritation within minutes, and higher 
concentrations producing proportionately greater and more rapid signs of 
irritation to nose and eyes (Schrenk et al. 1933). Histological 
examination of animals exposed to concentrations of 100 ppm or higher 
revealed marked congestion, edema and hemorrhage of the lung. Moderate 
congestion of brain, liver and kidneys was also noted in some animals, 
but this was judged to be secondary to the marked lung injury (Schrenk 
et al. 1933). Animals that survived the exposures recovered fully 
within 4 to 8 days, and had no histological signs of residual injury. 
Exposure of rats or guinea pigs to 69 ppm BCEE for 130 days did not 
result in significant changes in lung/body weight ratios, and did not 
lead to histological changes in lung (Dow Chemical 1958). 
 
Other Systemic Effects.  As noted above, short-term exposure of 
guinea pigs to 100 ppm resulted in moderate congestion of brain, liver, 
and kidneys, but this was judged to be secondary to lung injury (Schrenk 
et al. 1933). Longer-term exposure (130 days) of rats and guinea pigs 
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histological signs of injury to liver, kidney, heart, spleen, adrenal or 
pancreas, but did result in a significant decrease in body weight gain 
in both rats and guinea pigs (Dow Chemical 1958). Based on this, an 
intermediate inhalation MRL of 0.02 ppm has been calculated, as 
described in the footnote on Table 2-l. This value is also presented in 
Table l-l. 
 
The highest NOAEL values and all reliable LOAEL values for systemic 
effects in each species and duration category are recorded in Table 2-l 
and plotted in Figure 2-l. 
 
2.2.1.3   Immunological Effects 
 
No studies were located regarding immunological effects in humans 
or animals following inhalation exposure to BCEE. 
 
2.2.1.4   Neurological Effects 
 
No studies were located regarding neurological effects of BCEE 
inhalation in humans. However, data from animal studies indicate that 
BCEE is a central nervous system depressant, Schrenk et al. (1933) 
observed that guinea pigs exposed to concentrations of 100 ppm or higher 
began to become lethargic and uncoordinated within several hours, and 
that unconsciousness and death could follow. No effects on behavior 
were noted in guinea pigs or rats exposed to 69 ppm for 130 days (Dow 
Chemical 1958), but no details were provided on how behavior was 
evaluated. 
 
The highest NOAEL values and all reliable LOAEL values for 
neurological effects in each species and duration category are recorded 
in Table 2-l and plotted in Figure 2-l. 
 
2.2.1.5   Developmental Effects 
 
No studies were located regarding the developmental effects in 
humans or animals following inhalation exposure to BCEE. 
 
2.2.1.6   Reproductive Effects 
 
No studies were located regarding reproductive effects in humans 
following inhalation exposure to BCEE. In animals, no gross or 
histological effects were observed in reproductive tissues of rats and 
guinea pigs exposed to 69 ppm of BCEE for 18 weeks (Dow Chemical 1958), 
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2.2.1.7   Genotoxic Effects 
 
No studies were located regarding genotoxic effects in humans or 
animals following inhalation exposure to BCEE. 
 
2.2.1.8   Cancer 
 
Although no studies have been performed on the carcinogenic 
potential of BCEE following inhalation exposure, studies by the oral 
route (see Section 2.2.2.8, below) indicate that BCEE is carcinogenic in 
animals. Based on the oral data, EPA has calculated an inhalation unit 
risk of 3.3 x 10-4,( µg/m 3 )-1 (EPA 1988). Based on this, the 
concentrations of BCEE in air corresponding to estimated upper-bound 
excess lifetime cancer risk levels of 10-4, 10-5 and 10-6 are 0.05, 0.005 
and 0.0005 ppb, respectively. These values are shown in Figure 2-l. 
 
2.2.2   Oral Exposure 
 
No studies were located regarding health effects in humans 
following oral exposure to BCEE. Table 2-2 and Figure 2-2 summarize 
available toxicity data for oral exposure of animals to BCEE, and these 
data are discussed below. 
 
2.2.2.1  Death 
 
The acute oral LD50 for BCEE in rats is 75 mg/kg (Smyth and 
Carpenter 1948). This value has been converted to a corresponding 
concentration of 530 ppm in water for presentation in Table l-4. 
Similar acute oral LD50 values (105 to 136 mg/kg) were reported for 
mice, rabbits, and rats by Union Carbide (1948). Little information 
exists regarding lethality following chronic exposure. Decreased 
survival was reported in female rats dosed twice a week with 50 mg/kg 
for 18 months (Weisburger et al. 1981). The cause of the increased 
mortality was not determined. The dose of 50 mg/kg/day has been 
converted to an equivalent concentration of 360 ppm in water for 
presentation in Table l-4. 
 
The highest NOAEL values and all reliable LOAEL values for death in 
each species and duration category are recorded in Table 2-2 and plotted 
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2.2.2.2    Systemic Effects 
 
No studies were located regarding systemic effects in humans 
following oral exposure to BCEE. Weisburger et al. (1981) reported that 
oral exposure to doses of 25 or 50 mg/kg (twice a week for 78 weeks) 
resulted in decreased body weights in rats, but the magnitude of this 
effect was not described. The dose of 25 mg/kg/day has been converted 
to an equivalent concentration of 180 ppm in water for presentation in 
Table l-4. 
 
No studies were located on the following effects in humans or 
animals following oral exposure to BCEE: 
 
2.2.2.3   Immunological Effects 
 
2.2.2.4   Neurological Effects 
 
2.2.2.5   Developmental Effects 
 
2.2.2.6   Reproductive Effects 
 
2.2.2.7   Genotoxic Effects 
 
Jorgenson et al. (1978) dosed male mice for eight weeks with BCEE 
and observed no evidence of heritable reciprocal translocation of 
chromosomes. Since dose levels were not reported, the significance of 
these findings is difficult to judge. 
 
2.2.2.8   Cancer 
 
Innes et al. (1969) reported an increased incidence of hepatomas in 
two strains of mice exposed to an average dose of 41 mg/kg/day for 
80 weeks. The effect was most marked in the males, with liver tumors 
occurring in 53% and 88% of the exposed males of the two strains, 
compared with 10% and 6% in unexposed controls, respectively. A smaller 
effect (22% vs. 0%) was observed in females from one strain, but no 
effect was seen in females of the other strain. The authors of the 
study emphasized that although the tumors were described as hepatomas, 
the majority of tumors might have had malignant potential. No increased 
incidence of tumors was observed in male or female rats exposed twice a 
week  to doses of  25 or 50 mg/kg  (Weisburger et al. 1981). 
 
Based on the results of the study by Innes et al. (1969), and 
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ranked BCEE as a probable human carcinogen (Group B2). This category is 
for chemicals with adequate evidence of carcinogenicity in animals but 
inadequate evidence in humans.  The slope of the linear portion of the 
cancer dose-response curve at low doses (the ql*) was calculated to be 
1.1 (mg/kg/day)-1.   Based on this, daily intake of  9.1 x 10-7 mg/kg/day 
of BCEE for a lifetime corresponds to an excess cancer risk of no more 
than 1 x 10-6.  If exposure occurred by ingestion of water, this would 
correspond to a concentration of  3 x 10-5 mg/L for a 70-kg adult 
consuming 2 L/day.  If exposure occurred via food, this would correspond 
to a concentration of  3.2 x 10-5 ppm, assuming consumption of  0.028 kg 
of  food per kg of body weight per day. 
 
2.2.3   Dermal Exposure 
 
Table 2-3 summarizes available quantitative animal data on the 
toxic effects of BCEE following dermal or ocular exposure. 
 
2.2.3.1  Death 
 
BCEE has moderate dermal toxicity, with an estimated LD50 in 
rabbits of  870 mg/kg (Union Carbide 1948). Smyth and Carpenter (1948) 
and Union Carbide (1948) estimated that the amount absorbed through the 
skin of guinea pigs leading to death in 50% of the animals was about 
370-390 mg/kg. 
 
2.2.3.2   Systemic Effects 
 
Direct Dermal and Ocular Irritation. Smyth and Carpenter (1948) 
found that 10 mg of BCEE applied to the skin of rabbits caused 
irritation, and Carpenter and Smyth (1946) reported that 25 mg of BCEE 
(0.02 mL of  undiluted liquid) instilled in the eye of rabbits caused 
moderate irritation (a grade of 4 out of 10 was assigned). 
 
Other Systemic Effects. No studies were located regarding 
respiratory, cardiovascular, gastrointestinal, hematological, 
musculoskeletal, hepatic or renal effects in humans or animals following 
dermal exposure to BCEE. 
 
No studies were located regarding the following effects in humans 
or animals following dermal exposure to BCEE: 
 
2.2.3.3   Immunological Effects 
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2.2.3.5    Developmental Effects 
 
2.2.3.6    Reproductive Effects 
 
2.2.3.7    Genotoxic Effects 
 
2.2.3.8    Cancer 
 
Van Duuren et al. (1972) performed a two-stage initiation-promotion 
test for tumor production in mouse skin, using a single dose of BCEE (as 
the initiator) followed by repeated doses of phorbol myristate acetate 
(as promotor) for two years. The frequency of skin papillomas in the 
BCEE-treated mice (3/20) was not significantly different from the 
control group (2/20). Tests were not performed to investigate whether 
BCEE had any promotor activity, or if it was carcinogenic if applied 
repeatedly itself. 
 
2.3   RELEVANCE TO PUBLIC HEALTH 
 
Death.  Death in animals can occur from an exposure to high levels 
of BCEE by either inhalation (Carpenter et al. 1949;  Schrenk et al. 
1933), ingestion (Smyth and Carpenter 1948), or dermal contact (Smyth 
and Carpenter 1948; Union Carbide 1948). However, only one instance of 
human death thought to be due to BCEE exposure has been reported (Elkins 
1959). This was in a textile factory where exposure was probably quite 
high. In the environment, exposure to acutely lethal concentrations of 
BCEE is believed to be very unlikely. 
 
Systemic Effects.  The chief systemic health effect following 
inhalation exposure to BCEE is irritation to the respiratory tract 
(Schrenk et al. 1933). Because BCEE is so irritating, inhalation 
exposure conditions that are likely to cause significant injury to lung 
are easily detectable, and most people would presumably avoid such 
exposures. BCEE is similarly irritating to the skin following dermal 
contact (Smyth and Carpenter 1948), but no information was located on 
SystemicToxicity following dermal exposure. Oral exposure has been 
noted to result in decreased weight gain in animals (Weisburger et al. 
1981), but no information exists on toxicity to specific organ systems 
following oral exposure. 
 
Neurological Effects.  Inhalation exposure to BCEE has been 
observed to cause central nervous system depression (lethargy, ataxia, 
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nonspecific mechanism similar to other volatile halocarbon anesthetics, 
and such effects are likely to be reversible once exposure ceases. 
 
Other Noncarcinogenic Effects.   Studies have not been performed to 
determine whether BCEE exposure leads to immunologic, reproductive, 
developmental, or genotoxic effects in animals or humans. In the 
absence of more information on the toxicity and metabolism of this 
compound, it is difficult to predict whether such effects are likely to 
be of concern in exposed humans or not. 
 
Cancer.   The principal reason for concern with BCEE is its apparent 
carcinogenic potential. The most direct evidence indicating that BCEE 
is carcinogenic is the increased incidence of hepatomas in two strains 
of mice dosed orally for 80 weeks (Innes et al. 1969). This is 
supported by limited data indicating that BCEE is mutagenic in some 
bacterial test systems, although several studies have yielded negative 
results (Table 2-4). On the other hand, increased incidence of mouse 
liver hepatomas has been questioned as a reliable indication of true 
carcinogenic potential (Maronpot et al. 1987), and BCEE was not observed 
to cause a significant increase in tumors in a chronic feeding study in 
rats (Weisburger et al. 1981) or in parenteral exposure studies in mice 
(Theiss et al. 1977; Van Duuren et al. 1972) and rats (Norpoth et al. 
1986). Also, no binding of BCEE to DNA and no foci of ATPase-deficient 
cells (a sign of pre-neoplastic effects) were detected in liver of rats 
exposed to BCEE (Gwinner et al. 1983), and no evidence of heritable 
chromosome damage was detected in a preliminary study in mice (Jorgenson 
et al. 1978). Consequently, while the positive carcinogenicity findings 
in mice are adequate to conclude that BCEE may be a human carcinogen, 
the evidence on this point is limited. 
 
2.4   LEVELS IN HUMAN TISSUES AND FLUIDS ASSOCIATED WITH HEALTH EFFECTS 
 
No studies were located regarding levels of BCEE or its metabolites 
in human tissues or fluids. 
 
2.5   LEVELS IN THE ENVIRONMENT ASSOCIATED WITH LEVELS IN HUMAN TISSUES 
AND/OR HEALTH EFFECTS 
 
No studies were located regarding the relationship between exposure 
levels in air, food or water and resulting fluid levels or health 














2.6   TOXICOKINETICS 
 
2.6.1   Absorption 
 
2.6.1.1   Inhalation Exposure 
 
Quantitative data on BCEE absorption across the lung are limited. 
Gwinner et al. (1983) reported that rats placed in a chamber containing 
BCEE vapor absorbed over 95% of the compound within 18 hours. This 
indicates that BCEE is well absorbed following inhalation exposure, but 
it is not possible to estimate the inhalation absorption fraction from 
this observation. 
 
2.6.1.2   Oral Exposure 
 
Lingg et al. (1982) reported that only 2% of a single oral dose of 
BCEE administered to rats was excreted in the feces, indicating that 
absorption across the gastrointestinal tract was essentially complete. 
 
2.6.1.3   Dermal Exposure 
 
No studies were located regarding the rate or the extent of 
absorption by the dermal route. However, acute dermal toxicity studies 
(Smyth and Carpenter 1948) suggest that BCEE is well absorbed across the 
skin. 
 
2.6.2   Distribution 
 
2.6.2.1   Inhalation Exposure 
 
No studies were located regarding the distribution of BCEE in human 
or animal tissues following inhalation exposure. 
 
2.6.2.2   Oral Exposure 
 
Lingg et al. (1982) administered a single oral dose of 14C-labelled 
BCEE to rats, and measured the radioactive content of tissues 48 hours 
later. Only a small fraction of the dose (2.3%) was found in organs and 
tissues, with 0.96% in muscle, 0.56% in kidney, 0.49% in blood, 0.19% in 
liver, and 0.1% in other tissues. These findings suggest that BCEE is 
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2.6.2.3   Dermal Exposure
No studies were located regarding the distribution of BCEE in human
or animal tissues following dermal exposure.
2.6.3   Metabolism
Studies in animals indicate that BCEE is extensively metabolized,
with thiodiglycolic acid (TDGA) being the principal endproduct (Lingg
et al. 1979; Norpoth et al. 1986). The pathway leading to TDGA
formation is not certain, but probably involves oxidative cleavage of
the ether bond to yield chloroacetaldehyde and 2-chloroethanol, as shown
in Figure 2-3 (Bolt 1984; Gwinner et al. 1983; Norpoth et al. 1986;
Lingg et al. 1979, 1982; Muller and Norpoth 1979). TDGA recovered in
urine usually accounts for 50% to 80% of a dose of BCEE (Lingg et al.
1979, 1982). Smaller amounts of BCEE (3% to 5%) are metabolized by
oxidation or substitution at a chlorine without ether cleavage (see
Figure 2-3), and about 12% is degraded to CO2 (Lingg et al. 1982). Only
about 2% of the dose is excreted via the lungs as unchanged BCEE (Lingg
et al. 1979).
Gwinner et al. (1983) exposed rats to 14C-labelled BCEE vapor, and
measured the amount of radioactivity irreversibly bound to tissue
proteins 24 hours later. Distribution of unbound parent or metabolites
was not measured. Highest levels were found in liver, kidney and small
intestine, with much lower levels in lung, spleen and muscle. The
presence of protein-bound label in these tissues suggested to the
authors that reactive intermediates were formed that led to covalent
adducts, but incorporation of label into protein might also have
occurred through normal synthetic pathways involving non-toxic breakdown
products from BCEE. No label was detectable in liver DNA or RNA.
2.6.4   Excretion
Lingg et al. (1979, 1982) found that approximately 80% of an oral
dose of BCEE administered to rats was excreted within 48 hours. Most of
the dose (65%) was excreted as urinary metabolites (mostly
thiodiglycolic acid), with smaller amounts excreted in feces (3%) or
expired air (11% as CO2 and less than 2% as parent BCEE). Only 2% of
the dose remained in the body. This indicates that BCEE is effectively












2.7    INTERACTIONS WITH OTHER CHEMICALS 
 
No information was located on the interaction of BCEE with other 
chemicals. 
 
2.8    POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE 
 
No information was located to indicate that any human population 
might be especially susceptible to the toxic effects of BCEE. Based on 
the observation that BCEE is a powerful irritant of the respiratory 
tract, it may be expected that individuals with lung disease or other 
forms of respiratory distress might be particularly vulnerable to the 
effects of BCEE vapors. 
 
2.9    ADEQUACY OF THE DATABASE 
 
Section 104(i)(5) of CERCLA, directs the Administrator of ATSDR (in 
consultation with the Administrator of EPA and agencies and programs of 
the Public Health Service) to assess whether adequate information on the 
health effects of BCEE is available. Where adequate information is not 
available, ATSDR, in cooperation with the National Toxicology Program 
(NTP), is required to assure the initiation of a program of research 
designed to determine these health effects (and techniques for 
developing methods to determine such health effects). The following 
discussion highlights the availability, or absence, of exposure and 
toxicity information applicable to human health assessment. A statement 
of the relevance of identified data needs is also included. In a 
separate effort, ATSDR, in collaboration with NTP and EPA, will 
prioritize data needs across chemicals that have been profiled, 
 
2.9.1   Existing Information on Health Effects of BCEE 
 
As shown in Figure 2-4, there is very little information on the 
health effects of BCEE in humans. In animals, limited data exist on 
acute lethality and direct irritant effects, and there is some 
information on systemic effects following inhalation exposure. Several 
studies have investigated carcinogenicity following oral or dermal 
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2.9.2   Data Needs
Single Dose Exposure.  The effects of single exposures to BCEE have
not been thoroughly investigated. Estimates of acute inhalation
exposures that cause death in animals are available, but only one study
(Schrenk et al. 1933) provides dose-response data for more sensitive
endpoints of toxicity (lung irritation and edema). Further inhalation
studies using modern analytical and histological techniques would be
valuable in confirming and refining the limited data available on lung
injury, and in determining whether other tissues are injured as well.
Essentially no acute oral toxicity data exist except for one estimate of
the LD50 (Smyth and Carpenter 1948). For this reason, a thorough
investigation of the toxic effects following oral exposure in animals
would be useful.
Repeated Dose Exposure.   Only limited data (Dow Chemical 1958) are
available on the effects of repeated inhalation exposure to BCEE. This
study employed only one exposure level (69 ppm), so thresholds were not
established for any adverse effects following repeated exposures. For
this reason, further studies using modern histological and biochemical
tests would be useful in determining the NOAEL and LOAEL values for
injury to lung and other tissues. Although several chronic oral studies
have been performed (Innes et al. 1969, Weisburger et al. 1981), very
little information has been obtained on noncarcinogenic endpoints.
Consequently, studies to determine thresholds for systemic injury
following oral exposure would be valuable. Since residents near
industrial sources or waste sites that discharge BCEE are probably most
likely to be exposed through drinking water, studies using BCEE in water
would be especially helpful.
Chronic Exposure and Carcinogenicity.   Oral studies in mice are
adequate to establish that BCEE causes liver tumors in this species, but
there is debate over the relevance of this to other species, including
humans. For this reason further studies on the oral and inhalation
carcinogenicity of BCEE in several different species would be valuable.
Genotoxicity.   Several studies have been performed on the
genotoxicity of BCEE, and the results have been mixed (e.g., see
Table 2-4). Further studies to clarify the mutagenic and genotoxic
potential of BCEE would be valuable, especially if information could be












Reproductive Toxicity.  No studies were located on reproductive 
effects of BCEE. Single generation tests of reproductive toxicity 
following BCEE exposure (both oral and inhalation) would be valuable in 
determining whether this may be an effect of concern for humans. 
 
Developmental Toxicity.   No studies were located on the 
developmental effects of BCEE. Studies of teratogenic and fetotoxic 
potential would be valuable. 
 
Immunotoxicity.  No studies were located on the immunotoxicity of 
BCEE. Since the immune system is sometimes found to be sensitive to 
chemical agents, studies of the effects of BCEE on this system could be 
helpful. 
 
Neurotoxicity.  Inhalation exposure to high doses of BCEE appears 
to cause CNS depression and sedation (Schrenk et al. 1933), but the 
dose-response curve for this effect is not well defined. Further 
studies to identify the threshold for CNS depression and other effects 
on behavior following both oral and inhalation exposure would be 
helpful. In addition, studies employing modern histological and 
electrophysiological techniques would be valuable in determining if 
cells of the CNS are structurally injured by exposure to BCEE. 
 
Epidemiological and Human Dosimetry Studies.   No epidemiological 
studies were located in humans exposed to BCEE. Performance of such 
studies could be helpful in evaluating the chronic human health risk 
from BCEE exposure, especially cancer. 
 
Biomarkers of Disease.  No biomarkers of BCEE-induced disease in 
humans are known. Since the principal effect associated. with inhalation 
exposure is nonspecific lung irritation, it may be difficult to develop 
preclinical indices of potential lung injury that are specific for BCEE. 
 
Bioavailability from Environmental Media.  No studies were located 
on the relative bioavailability of BCEE in different environmental 
media. Based on the physical properties of BCEE, it would not be 
expected that bioavailability would vary widely between media, but 
studies to investigate this would be helpful in risk assessments 














Food Chain Bioaccumulation.   No studies were located on food chain 
bioaccwnulation of BCEE. Based on the observation that BCEE metabolism 
is rapid and essentially complete in rats, accumulation of BCEE in the 
tissues of mammals does not appear likely. Studies on BCEE retention in 
several species besides rat would be helpful to confirm this, however. 
The studies on BCEE accumulation in fish and plants would also be 
valuable. 
 
Absorption, Distribution, Metabolism, and Excretion.  Although 
there are limited toxicokinetic data on BCEE from studies of animals, 
there are several areas where additional information would be valuable. 
Since available information is derived from studies employing single 
exposures, studies of uptake, distribution and excretion patterns 
following repeated exposures would be useful. Quantitative studies of 
absorption rates across the lungs and the skin would be helpful is 
estimating absorbed doses and resultant health effects following 
inhalation and dermal exposure. Additional metabolism studies would be 
valuable in identifying intermediate metabolites which might be involved 
in the genotoxic or carcinogenic effects of BCEE. Finally, further 
studies of the kinetics of BCEE metabolism and clearance would be 
valuable in evaluating the potential for cumulative toxicity. 
 
Comparative Toxicokinetics.  Toxicokinetic studies of BCEE 
metabolism and excretion have been performed in rats (Gwinner et al. 
1983; Lingg et al. 1979; Muller and Norpoth 1979; Norpoth et al. 1986). 
Consequently, studies of metabolism in other species would be valuable, 
especially in mice (since a carcinogenic response has been observed in 
mice but not in rats). In addition, studies of the pattern of BCEE 
degradation products in human urine would be helpful in evaluating 
whether BCEE is metabolized in humans as it is in rats. 
 
2.9.3   Ongoing Studies 
 
No information was located on any ongoing studies on the health 









3.  CHEMICAL AND PHYSICAL INFORMATION 
 
 
3.1   CHEMICAL IDENTITY 
 
Table 3-l lists common synonyms, trade names and other pertinent 
identification information for BCEE. 
 
3.2   PHYSICAL AND CHEMICAL PROPERTIES 
 


















4.1   PRODUCTION 
 
All BCEE produced in the United States is made by direct 
chlorination of ethylene glycol (Buckman Laboratories 1988). BCEE can 
also be produced by the treatment of ethylene chlorohydrin or 
2-chloroethanol with sulfuric acid, or by chlorination of ethylene 
chlorohydrin at 80°C. Production of BCEE in the United States in 1986 
was estimated to be 1,200 kkg (Buckman Laboratories 1988). 
 
4.2   IMPORT 
 
Imports of BCEE in 1977 were estimated to be about 590 kkg (HSDB 
1988). Imports of BCEE in 1986 were estimated to be about 60 kkg 
(Buckman Laboratories 1988). 
 
4.3   USE 
 
In the past, BCEE has been used as a solvent for fats, waxes, 
greases and esters (Schrenk et al. 1933). It has also been used as a 
constituent of paints and varnishes, as a cleaning fluid for textiles, 
in the purification of oils and gasoline, in the manufacture of 
medicines and pharmaceuticals, as an intermediate in the synthesis of 
other chemicals, and as an insecticide and a soil fumigant (Browning 
1965; Hake and Rowe 1963; HSDB 1988; Verschueren 1977; Windholz 1983). 
 
BCEE is currently used primarily as a chemical intermediate for the 
manufacture of pesticides. The two major pesticide products made from 
BCEE are WSCP, an isoprene polymer used primarily as an algicide, and 
CDQ, a diquaternary ammonium compound used as a microbicide and 
corrosion inhibitor in the petroleum industry. A small amount of BCEE 
(about 1%) is still used as a solvent. 
 
4.4   DISPOSAL 
 
No information was located on the amounts of BCEE disposed of to 
the environment or to waste sites. Because BCEE is classified as a 
hazardous waste under the Resource Conservation and Recovery Act (RCRA), 
all BCEE waste must be disposed of in an authorized RCRA facility. 
Permitted disposal methods include incineration and land disposal, 
although EPA is currently considering possible restrictions on land disposal 













4.5   ADEQUACY OF THE DATABASE 
 
Section 104(i)(5) of CERCLA, directs the Administrator of ATSDR (in 
consultation with the Administrator of EPA and agencies and programs of 
the Public Health Service) to assess whether adequate information on the 
health effects of BCEE is available. Where adequate information is not 
available, ATSDR, in cooperation with the National.Toxicology Program 
(NTP), is required to assure the initiation of a program of research 
designed to determine these health effects (and techniques for 
developing methods to determine such health effects). The following 
discussion highlights the availability, or absence, of exposure and 
toxicity information applicable to human health assessment. A statement 
of the relevance of identified data needs is also included. In a 
separate effort, ATSDR, in collaboration with NTP and EPA, will 
prioritize data needs across chemicals that have been profiled. 
 
4.5.1   Data Needs 
 
Production, Import, Use, and Disposal.   Data are available on the 
production, import and general use patterns, but more complete 
information on present disposal volumes and methods would be valuable in 
estimating the likelihood and possible magnitude of further 
environmental contamination with BCEE. 
 
According to the Emergency Planning and Community Right to Know Act 
of 1986 (EPCRTKA), (§313), (Pub. L. 99-499, Title III, §313), industries 
are required to submit release information to the EPA. The Toxic 
Release Inventory (TRI), which contains release information for 1987, 
became available in May of 1989. This database will be updated yearly 















5.1   OVERVIEW 
 
Relatively little information is available on human exposure to 
BCEE. In the workplace, the most likely exposure routes are inhalation 
or dermal contact. For the general public, the most likely route is 
ingestion of BCEE in drinking water. Low levels of BCEE have been 
detected in some drinking water systems, and BCEE has been detected in 
groundwater at about 2% of the waste sites being investigated under 
Superfund. The most likely means of exposure near these sites is 
consumption of contaminated water, but dermal contact and inhalation 
exposure might also occur. 
 
5.2   RELEASES TO THE ENVIRONMENT 
 
No studies were located regarding the amount of BCEE being released 
from industrial processes or waste sites into air, water or soil. 
 
5.3   ENVIRONMENTAL FATE 
 
5.3.1   Transport and Partitioning 
 
Little information was located on the transport or partitioning of 
BCEE in the environment. The vapor pressure of BCEE at 20°C is 
0.7 mm Hg (Verschueren 1977), suggesting that volatilization from soil 
or water, while probably very slow, could be significant (Callahan 
et al. 1979). EPA (1987a) calculated a half-time for volatilization of 
BCEE from a river to be 3.4 days. Because BCEE is quite soluble in 
water (10,200 mg/L) (Verschueren 1977), it is expected that BCEE in air 
would tend to be removed by wet deposition, resulting in a cycle between 
water, soil and air (Callahan et al. 1979). The relative distribution 
between these phases, however, is not known. 
 
Because BCEE has good solubility in water and a relatively low log 
octanol-water partition coefficient (measured to be 1.1 by Veith et al. 
1980), BCEE in aqueous media is not expected to adsorb strongly to 
sediments, nor is it likely to be bioaccumulated by aquatic organisms 
(Callahan et al. 1979). Consistent with this, a bioconcentration factor 




5.    POTENTIAL FOR HUMAN EXPOSURE
For the same reasons, BGEE is not expected to adsorb strongly to
soils, and would be expected to migrate in soil water. Consistent with
this, Wilson et al. (1981) reported a soil retardation factor of <1.5
for sandy soil with low organic content, while other contaminants (e.g.,
di- and trichlorobenzene) had retardation factors of 3.4 to 9.4.
5.3.2   Transformation and Degradation
5.3.2.1   Air
Callahan et al. (1979) reviewed the potential fate of BCEE in the
environment and suggested that BCEE in a smog-like atmosphere would
probably undergo photooxidative destruction with a half-life of
approximately four hours. The rate of atmospheric photooxidation under
other conditions was not estimated. Direct photolysis was judged to be
an unimportant process, since BCEE does not absorb visible or near ultraviolet
light (Callahan et al. 1979).
5.3.2.2   Water
Most ethers are very resistant to hydrolysis, and the rate of
cleavage of the carbon-oxygen bond by abiotic processes is expected to
be insignificant (Callahan et al. 1979). The carbon-chlorine bond is
also quite stable to abiotic cleavage. Based on a measured hydrolysis
rate constant of 1.5x10-5min –1 at l00ºC, Mabey et al. (1982) estimated
the half-life of the carbon-chlorine bond to be about 22 years at 20°C.
This rate is somewhat slower than observed for simple alkyl halides
(Callahan et al. 1979; Mabey et al. 1982), an effect which Mabey et al.
(1982) attributed to the effect of the chloro-ethoxy group on the
adjacent carbon.
Biodegradation may be an important fate process for BCEE in water.
In laboratory studies, Tabak et al. (1981) found that in aqueous media
inoculated with sewage, BCEE underwent 100% transformation within seven
days, and there was a rapid adaptation of the degradative
microorganisms. Similar results were reported by Ludzack and Ettinger
(1963), although in this case there was a 25 day lag before adaption
occurred, and 30 more days were required to convert 80% of the BCEE to
CO2. A second dose of BCEE added to the adapted medium was 80% oxidized
in 15 days. Monsen (1986) reported that BCEE also underwent significant
biodegradation (68%) in an anaerobic laboratory test pond designed to
simulate an industrial primary lagoon. Losses via evaporation and
sorption were minimal. In contrast to these findings, Dojlido (1979)











test systems. The reason for this discrepancy is not certain, but may 
be due to insufficient incubation time (two weeks) for the adaptation to 
occur. Biodegradation in surface waters would likely be slower than 
observed in the laboratory, but could lead to significant destruction of 
BCEE. 
 
5.3.2.3   Soil 
 
Wilson et al. (1981) observed no significant transformation of BCEE 
percolated through soil for 45 days, but Kincannon and Lin (1986) found 
that BCEE was significantly degraded in a 97-day laboratory soil column 
study. The initial rate constant for degradation was reported to be 
0.042 day-1 (half-time of 16.7 days). After 48 days, the rate increased 
to 0.086 day-1 (half-time of 8.0 days), suggesting that there was an 
acclimation of soil microbes occurring. 
 
5.4   LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT 
 
5.4.1   Air 
 
No studies were located with regard to concentrations of BCEE in 
ambient air. Based on the physical-chemical properties of BCEE, some 
release of BCEE into air from contaminated chemical waste sites or 
industrial settings is expected, but no quantitative data were located. 
 
5.4.2   Water 
 
In 1977, the EPA carried out an extensive study (the National 
Organics Monitoring Survey) of organic contaminants in finished drinking 
water supplies across the United States. BCEE was not detected in any 
samples in Phase I of the study, but the detection limit was only 
5 µg/L.  In phase II, the detection limit was lowered to 0.005 µg/L, and 
BCEE was detected in water from 13 of 113 cities sampled. The values 
ranged from 0.01 to 0.36 µg/L, with a mean concentration (for the 13 
positive samples) of 0.1 µg/L (Dressman et al. 1977). In phase III of 
the Survey, BCEE was detected in drinking water from 8 of 110 cities, 
with a mean concentration of  0.024 µg/L. Trace quantities of BCEE have 
been reported in several rivers, including the Mississippi, the Delaware 
and the Kanawha (Staples et al. 1985; EPA 1987a). BCEE was detected in 
ground water at about 2% of waste disposal sites being investigated 















5.4.3   Soil 
 
BCEE was detected in soil at only 0.4% of waste sites monitored 
under Superfund, at geometric mean concentration of 140 ppb (CLPSD 
1988). 
 
5.4.4   Other Media 
 
No studies were located regarding the occurrence of BCEE in food or 
other media. 
 
5.5   GENERAL POPULATION AND OCCUPATIONAL EXPOSURE 
 
The primary known source of exposure for the general population is 
via the water supply. The reports of quantities in several drinking 
water supplies provided a mean value of approximately 0.1 ppb. 
Ingestion of approximately 2 liters of water per day by an adult would 
provide a daily intake of 0.003 µg/kg/day of BCEE. Based on the slope 
factor of 1.1 (mg/kg/day)-1 (see Section 2.2.2.8), this corresponds to 
an upperbound lifetime cancer risk from this source of about 3 x 10-6. 
 
No studies were located regarding exposure of workers to BCEE. 
 
5.6   POPULATIONS WITH POTENTIALLY HIGH EXPOSURES 
 
Even though there are no exposure data, those at greatest risk of 
exposure to BCEE are probably workers who are exposed to BCEE while on 
the job. Residents who live near waste sites or industrial facilities 
that permit escape of BCEE may also experience higher than average 
exposure to BCEE. Exposure would be most likely by ingestion of 
contaminated water, but inhalation exposure might also occur. The level 
and significance of such exposures can only be evaluated on a site-by site 
basis. 
 
5.7   ADEQUACY OF THE DATABASE 
 
Section 104(i)(5) of CERCLA, directs the Administrator of ATSDR (in 
consultation with the Administrator of EPA and agencies and programs of 
the Public Health Service) to assess whether adequate information on the 
health effects of BCEE is available. Where adequate information is not 
available, ATSDR, in cooperation with the National Toxicology Program 
(NTP), is required to assure the initiation of a program of research 
designed to determine these health effects (and techniques for 














discussion highlights the availability, or absence, of exposure and 
toxicity information applicable to human health assessment.  A statement 
of the relevance of identified data needs is also included. In a 
separate effort, ATSDR, in collaboration with NTP and EPA, will 
prioritize data needs across chemicals that have been profiled. 
 
5.7.1   Data Needs 
 
Physical and Chemical Properties.   The physical and chemical 
properties of BCEE have been determined (Table 3-l), and further 
research on these properties does not appear to be essential. 
 
Environmental Fate.   Although there is information which provides a 
general prediction of the likely fate and transport of BCEE in the 
environment, quantitative data are not available for most fate 
processes. Reliable quantitative data on rates of volatilization from 
water and soil, atmospheric oxidation, hydrolysis in water, and 
biodegradation in soil and water would be useful in estimating likely 
concentrations of BCEE in air, soil and water around waste sites and 
other possible sources of BCEE emissions. 
 
Exposure Levels in Environmental Media.   Available data suggest 
that contamination of water may occur around chemical waste sites or 
industrial facilities where BCEE is present. For this reason, 
additional monitoring data on BCEE concentrations in water (both surface 
water and ground water) around such sites would be valuable. Monitoring 
of BCEE levels in air, soil, fish, and possibly other foods would be 
helpful in estimating the significance of exposures through these media. 
 
Exposure Levels in Humans. Information on exposure of the general 
population to BCEE is limited. The compound has been reported in 
drinking water in some locations, but many water supplies have not been 
tested. It would appear that an increased monitoring of drinking water 
supplies for this compound would be beneficial. Similarly, data on 
typical occupational exposure levels and durations would be valuable in 
estimating doses to workers, and data on exposure levels around chemical 
waste sites would be valuable in determining whether nearby residents 













Exposure Registries.   No registry exists for humans known to have 
been exposed to BCEE. Creation of such a registry would be valuable in 
collection of further information on the health effects of BCEE on 
humans, especially chronic effects (such as cancer) that do not become 
manifest at the time of exposure. 
 
5.7.2   On-going Studies 
 
No information was located regarding on-going studies on the 
environmental fate of BCEE, or on BCEE levels in the ambient 
environment. Remedial investigations being performed under Superfund at 
chemical waste sites will provide additional data on the occurrence of 
BCEE in water, soil and possibly in air at these locations, and on the 














6.1   BIOLOGICAL MATERIALS 
 
No methods were located that are routinely used for the detection 
of BCEE in biological materials. Norpoth et al. (1986) reported a 
method for measuring thiodiglycolic acid (the principal animal 
metabolite of BCEE) in the urine of rats. This method employed an ion 
exchange isolation of TDGA followed by gas chromatographic analysis 
using a flame ionization detector. Sensitivity was not reported, but 
the method was able to detect a two-fold increase in thiodiglycolic acid 
(TDGA) excretion (from 0.37 to 0.72 µmo1/24 hours) resulting from an 8- 
hour exposure to 10 ppm BCEE. 
 
6.2   ENVIRONMENTAL SAMPLES 
 
BCEE in environmental samples is most commonly determined by gas 
chromatography with a halogen-specific detector (GC/HSD) (Dressman 
et al. 1977; EPA 1982a), gas chromatography/mass spectrometry (GC/MS) 
(EPA 1986a), or capillary column gas chromatography/Fourier transform 
infrared (GC/FT-IR) spectrometry (EPA 1986c). 
 
The determination of BCEE in air requires passing the air samples 
through a sorbent, followed by elution of adsorbed BCEE from the sorbent 
and gas chromatographic measurement. Coconut shell charcoal is the 
favored sorbent, carbon disulfide is used for elution, and gas 
chromatography is employed for analysis (NIOSH 1984). 
 
The EPA has developed a method of analysis specifically for 
haloethers in water (EPA 1982a).  These compounds include bis(2- 
chloroethyl), bis(2-chloroisopropyl), 4-chlorophenol phenyl, and 4- 
bromophenol phenyl ethers, and bis(2-chloroethoxy) methane. The 
analysis involves an extraction into dichloromethane solvent, 
concentration by evaporation with exchange to hexane, and Florisil 
cleanup prior to gas chromatographic measurement. Other standard EPA 
methods are adapted to the determination of BCEE in wastes. 
 
If BCEE is identified in a sample by a GC procedure other than 
GC-MS, it is important to confirm the identification by a second method. 
For example, in a survey of water samples from 113 cities, 44 samples 
were tentatively found to contain BCEE. Reanalysis of these samples 
(either by using a different GC column, or by separating interfering 
components with Florisil prior to GC analysis) indicated that only 13 of 
the 44 tentatively-identified samples actually contained BCEE (Dressman 
et al. 1977). Thus, false positive results are likely if confirmatory 














Methods for the determination of BCEE in environmental samples are 
summarized in Table 6-l. 
 
6.3    ADEQUACY OF THE DATABASE 
 
Section 104(i)(5) of CERCLA, directs the Administrator of ATSDR (in 
consultation with the Administrator of EPA and agencies and programs of 
the Public Health Service) to assess whether adequate information on the 
health effects of BCEE is available. Where adequate information is not 
available, ATSDR, in cooperation with the National Toxicology Program 
(NTP), is required to assure the initiation of a program of research 
designed to determine these health effects (and techniques for 
developing methods to determine such health effects). The following 
discussion highlights the availability, or absence, of exposure and 
toxicity information applicable to human health assessment. A statement 
of the relevance of identified data needs is also included. In a 
separate effort, ATSDR, in collaboration with NTP and EPA, will 
prioritize data needs across chemicals that have been profiled. 
 
6.3.1   Data Needs 
 
Methods for Determining Parent Compound and Metabolites in 
Biological Materials. Since there are no standard methods for analysis 
of BCEE in biological materials, development of such methods would be 
useful. The properties of this compound suggest that it should be 
amenable to determination in biological samples. It is a relatively 
high-boiling liquid (178°C) with a low log octanol/water partition 
coefficient, extractable from water into dichloromethane, relatively 
stable to hydrolysis, and easily measured by gas chromatography. The 
high boiling temperature suggests that purge-and-trap and headspace 
techniques may not be readily applicable to the determination of BCEE in 
biological samples, but techniques based upon solvent extraction should 
work well. 
 
Norpoth et al. (1986) reported a method for measuring TDGA in 
urine. Although this is the principal animal metabolite of BCEE, it 
occurs naturally in the urine of control animals and is also formed by 
metabolism of other chemicals. For these reasons, it would be helpful 
to develop methods for the detection and quantification of urinary 
metabolites that are unique to BCEE, such as N-acetyl-S-[2- 














Methods for Biomarkers of Exposure. No routine tests for 
biomarkers of exposure to BCEE were located. Using radioactively labeled 
BCEE, Gwinner et al. (1983) reported incorporation of label into 
cellular proteins of animals exposed to BCEE. Studies to determine if 
this is due to protein adduct formation would be valuable. If so, 
immunological assays might be developed to detect such adducts formed 
from reaction of unlabeled BCEE with proteins such as albumin or 
hemoglobin. Gwinner et al. (1983) did not detect label in DNA or RNA 
from animals exposed to BCEE, suggesting that adduct formation with 
these macromolecules might not be a sensitive biomarker of exposure. 
 
Methods for Determining Parent Compounds and Degradation Products 
in Environmental Media.  Although methods exist for the determination of 
BCEE in environmental samples, detection limits (see Table 6-l) are not 
adequate to measure BCEE in water or air at the concentrations estimated 
to correspond to the l0-6 risk level for cancer (0.03 ppb in water, 
0.003 µg/m3 in air). Consequently, improvements in sensitivity would be 
helpful. The problem of high humidity interfering with the collection 
of BCEE from air (lowered breakthrough volume) should also be addressed. 
 
6.3.2   Ongoing Studies 
 
Supercritical fluid extraction/chromatography and immunoassay are 
two areas of intense current activity from which substantial advances in 
the determination of BCEE and metabolites in biological samples can be 
anticipated. The two techniques are complementary in that supercritical 
fluid extraction is especially promising for the removal of analytes 
from sample material (Hawthorne 1988) while immunoassay is very 
selective and sensitive (Vanderlaan et al. 1988). 
 
An especially promising approach to the determination of BCEE in 
biological samples is supercritical fluid extraction coupled with 
supercritical fluid chromatography. This combination has been described 
for the determination of sulfonylurea herbicides and their metabolites 
in complex matrices, including soil, plant materials, and cell culture 
medium (McNally and Wheeler 1988). The approach described in this work 













Thermospray techniques interfaced with mass spectrometry, with or 
without high performance liquid chromatographic separation, are proving 
useful for the determination of thermally labile compounds (as are some 
toxicant metabolites), and should be applicable to the determination of 
BCEE and its metabolites in biological materials (Korfmacher et al. 
1987; Betowski et al. 1987). 
 
The EPA is funding an ongoing effort to develop a master analytical 
scheme for organic compounds in water (Michael et al. 1988). The 
overall goal is the development of a technology capable of detecting and 
quantifying organic compounds at  0.1 µg/L in drinking water, 1 µg/L in 
surface waters, and 10 µg/L in effluent waters. Analytes are to include 
numerous semivolatile compounds and some compounds that are only semisoluble 
in water, as well as volatile compounds. A comprehensive review 
of the literature leading to these efforts has been published 
(Pellizzari et al. 1985). It may be anticipated that improved methods 
for the determination of BCEE in environmental samples will be developed 
as part of this effort. 
 
The current high level of activity in supercritical fluid 
extraction of solid and semisolid samples should yield improved 
recoveries and sensitivities for the determination of BCEE in solid 
wastes, and the compound should be amenable to supercritical fluid 
chromatographic analysis. Immunoassay analysis (Vanderlaan et al. 1988) 
is an area of intense current activity from which substantial advances 
















Because of its potential to cause adverse health effects in exposed 
people, a number of regulations and advisory values have been 
established for BCEE by various international, national and state 
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Acute Exposure -- Exposure to a chemical for a duration of 14 days or 
less, as specified in the Toxicological Profiles. 
 
Adsorption Coefficient (Koc) -- The ratio of the amount of a chemical 
adsorbed per unit weight of organic carbon in the soil or sediment to 
the concentration of the chemical in solution at equilibrium. 
 
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment 
or soil (i.e., the solid phase) divided by the amount of chemical in the 
solution phase, which is in equilibrium with the solid phase, at a fixed 
solid/solution ratio. It is generally expressed in micrograms of 
chemical sorbed per gram of soil or sediment. 
 
Bioconcentration Factor (BCF) -- The quotient of the concentration of a 
chemical in aquatic organisms at a specific time or during a discrete 
time period of exposure divided by the concentration in the surrounding 
water at the same time or during the same time period. 
 
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study or 
group of studies which produces significant increases in incidence of 
cancer (or tumors) between the exposed population and its appropriate 
control. 
 
Carcinogen -- A chemical capable of inducing cancer. 
 
Ceiling value (CL) -- A concentration of a substance that should not be 
exceeded, even instantaneously. 
 
Chronic Exposure -- Exposure to a chemical for 365 days or more, as 
specified in the Toxicological Profiles. 
 
Developmental Toxicity -- The occurrence of adverse effects on the 
developing organism that may result from exposure to a chemical prior to 
conception (either parent), during prenatal development, or postnatally 
to the time of sexual maturation. Adverse developmental effects may be 
detected at any point in the life span of the organism. 
 
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as 
a result of prenatal exposure to a chemical; the distinguishing feature 
between the two terms is the stage of development during which the 
insult occurred. The terms, as used here, include malformations and 















EPA Health Advisory -- An estimate of acceptable drinking water levels 
for a chemical substance based on health effects information. A health 
advisory is not a legally enforceable federal standard, but serves as 
technical guidance to assist federal, state, and local officials. 
 
Immediately Dangerous to Life or Health (IDLH) -- The maximum 
environmental concentration of a contaminant from which one could escape 
within 30 min without any escape-impairing symptoms or irreversible 
health effects. 
 
Intermediate Exposure -- Exposure to a chemical for a duration of 15-364 
days, as specified in the Toxicological Profiles. 
 
Immunologic Toxicity -- The occurrence of adverse effects on the immune 
system that may result from exposure to environmental agents such as 
chemicals. 
 
In vitro -- Isolated from the living organism and artificially 
maintained, as in a test tube. 
 
In vivo -- Occurring within the living organism. 
 
Lethal Concentration(LO) (LCLO) -- The lowest concentration of a 
chemical in air which has been reported to have caused death in humans 
or animals. 
 
Lethal Concentration(50) (LC50) -- A calculated concentration of a 
chemical in air to which exposure for a specific length of time is 
expected to cause death in 50% of a defined experimental animal 
population. 
 
Lethal Dose(LO) (LDLO) -- The lowest dose of a chemical introduced by a 
route other than inhalation that is expected to have caused death in 
humans or animals. 
 
Lethal Dose(50) (LD50) -- The dose of a chemical which has been 





9.    GLOSSARY
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of
chemical in a study or group of studies which produces statistically or
biologically significant increases in frequency or severity of adverse
effects between the exposed population and its appropriate control.
LT50 (lethal time) -- A calculated period of time within which a
specific concentration of a chemical is expected to cause death in 50%
of a defined experimental animal population.
Malformations -- Permanent structural changes that may adversely affect
survival, development, or function.
Minimal Risk Level -- An estimate of daily human exposure to a chemical
that is likely to be without an appreciable risk of deleterious effects
(noncancerous) over a specified duration of exposure.
Mutagen -- A substance that causes mutations. A mutation is a change in
the genetic material in a body cell. Mutations can lead to birth
defects, miscarriages, or cancer.
Neurotoxicity -- The occurrence of adverse effects on the nervous system
following exposure to a chemical.
No-Observed-Adverse-Effect Level (NOAEL) -- That dose of chemical at
which there are no statistically or biologically significant increases
in frequency or severity of adverse effects seen between the exposed
population and its appropriate control. Effects may be produced at this
dose, but they are not considered to be adverse.
Octanol-Water Partition Coefficient (Kow) -- The equilibrium ratio of
the concentrations of a chemical in n-octanol and water, in dilute
solution.
Permissible Exposure Limit (PEL) -- An allowable exposure level in
workplace air averaged over an 8-h shift.
q1* -- The upper-bound estimate of the low-dose slope of the doseresponse
curve as determined by the multistage procedure. The q1* can
be used to calculate an estimate of carcinogenic potency, the
incremental excess cancer risk per unit of exposure (usually µg/L for











Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps 
an order of magnitude) of the daily exposure of the human population to 
a potential hazard that is likely to be without risk of deleterious 
effects during a lifetime. The RfD is operationally derived from the 
NOAEL (from animal and human studies) by a consistent application of 
uncertainty factors that reflect various types of data used to estimate 
RfDs and an additional modifying factor, which is based on a 
professional judgment of the entire database on the chemical. The RfDs 
are not applicable to nonthreshold effects such as cancer. 
 
Reportable Quantity (RQ) -- The quantity of a hazardous substance that 
is considered reportable under CERCLA. Reportable quantities are: (1) 1 
lb or greater or (2) for selected substances, an amount established by 
regulation either under CERCLA or under Sect. 311 of the Clean Water 
Act. Quantities are measured over a 24-h period. 
 
Reproductive Toxicity -- The occurrence of adverse effects on the 
reproductive system that may result from exposure to a chemical. The 
toxicity may be directed to the reproductive organs and/or the related 
endocrine system. The manifestation of such toxicity may be noted as 
alterations in sexual behavior, fertility, pregnancy outcomes, or 
modifications in other functions that are dependent on the integrity of 
this system. 
 
Short-Term Exposure Limit (STEL) -- The maximum concentration to which 
workers can be exposed for up to 15 min continually. No more than four 
excursions are allowed per day, and there must be at least 60 min 
between exposure periods. The daily TLV-TWA may not be exceeded. 
 
Target Organ Toxicity -- This term covers a broad range of adverse 
effects on target organs or physiological systems (e.g., renal, 
cardiovascular) extending from those arising through a single limited 
exposure to those assumed over a lifetime of exposure to a chemical. 
 
TD50 (toxic dose) -- A calculated dose of a chemical, introduced by a 
route other than inhalation, which is expected to cause a specific toxic 
effect in 50% of a defined experimental animal population. 
 
Teratogen -- A chemical that causes structural defects that affect the 














Threshold Limit Value (TLV) -- A concentration of a substance to which 
most workers can be exposed without adverse effect, The TLV may be 
expressed as a TWA, as a STEL, or as a CL. 
 
Time-weighted Average (TWA) -- An allowable exposure concentration 
averaged over a normal 8-h workday or 40-h workweek. 
 
Uncertainty Factor (UP) -- A factor used in operationally deriving the 
RfD from experimental data. UFs are intended to account for (1) the 
variation in sensitivity among the members of the human population, (2) 
the uncertainty in extrapolating animal data to the case of humans, (3) 
the uncertainty in extrapolating from data obtained in a study that is 
of less than lifetime exposure, and (4) the uncertainty in using LOAEL 
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